Determining the frequency of pulmonary tuberculosis in patients presenting with bronchogenic carcinoma at tertiary care hospital, Karachi

Authors

  • Komal Sikander Ojha Institute of Chest Diseases/ Dow University of Health Sciences, Karachi Pakistan
  • Faisal Asad Ojha Institute of Chest Diseases/ Dow University of Health Sciences, Karachi Pakistan
  • Muzamil Ahmed Ojha Institute of Chest Diseases/ Dow University of Health Sciences, Karachi Pakistan
  • Purwa Kumari Ojha Institute of Chest Diseases/ Dow University of Health Sciences, Karachi Pakistan
  • Aftab Ahmed Ojha Institute of Chest Diseases/ Dow University of Health Sciences, Karachi Pakistan
  • Asim Shafeeque Channar Ojha Institute of Chest Diseases/ Dow University of Health Sciences, Karachi Pakistan

DOI:

https://doi.org/10.61529/idjp.v35i2.529

Abstract

Background: Pulmonary tuberculosis (PTB) may accompany bronchogenic carcinoma, making it very difficult to diagnose and treat.

Material and Methods: A descriptive cross-sectional study was carried out at Outpatient Department of Pulmonology, Ojha Institute of Chest Diseases, Karachi, 1st November 2025 – 30th April 2026.  Consecutive enrolment of adult patients with histopathologically or radiologically confirmed bronchogenic carcinoma was done (n = 97). The diagnosis of PTB was done by acid-fast bacilli (AFB) smear, Lowenstein-Jensen media culture, or Xpert MTB/RIF assay. Chi-square or Fisher exact tests were used to analyze the association between PTB and patient characteristics and multivariate logistic regression was used to determine independent predictors. P value of less than or equal to 0.05 was considered to be significant.

Results: The study involved 97 patients who were diagnosed with bronchogenic carcinoma. The mean age was 58.4 ± 11.7 years, and 62.9% were males. The diagnosis of pulmonary tuberculosis (PTB) was made in 38 patients (39.2%). In the multivariate logistic regression analysis, male sex (AOR = 3.18, p = 0.048), rurality (AOR = 6.85, p < 0.001), low education (AOR = 4.72, p = 0.015), and low income (AOR = 5.90, p = 0.014) were independently associated with an increased likelihood of pulmonary tuberculosis (PTB) among patients with bronchogenic carcinoma.

Conclusion: PTB was prevalent among bronchogenic carcinoma patients. Male gender, rural residence, low education, and low income were significantly associated with a higher likelihood of PTB, whereas age showed no significant association.

Keywords: Bronchogenic Carcinoma, Comorbidity, Cross-Sectional studies, Pulmonary tuberculosis.

References

Pereira JNDA, Samiasih A. Pulmonary tuberculosis as a risk factor for lung cancer: A systematic review. Open Access Res J Sci Technol. 2025;14(1):82–89. Available from: https://oarjst.com/sites/default/files/OARJST-2025-0076.pdf

Kumar A, Akhter R, Khtari N, Saifullah N, Rizvi N. Frequency of tuberculosis in patients with lung cancer. Pak J Med Health Sci. 2022; 16(8): 299–300. DOI: https://doi.org/10.53350/pjmhs22168299

Qi F, Yang H, Han Y, Dong Y, Zhang F, Wang Y, et al. Coexistent pulmonary tuberculosis and lung cancer: an analysis of incidence trends, financial burdens and influencing factors. Cancer Innov. 2025; 4(3): e70009. DOI: https://doi.org/10.1002/cai2.70009

Zhang F, Qi F, Han Y, Yang H, Wang Y, Wang G, et al. Clinical and imaging features of co-existent pulmonary tuberculosis and lung cancer: A population-based matching study in China. BMC Cancer. 2025; 25: 89. DOI: https://doi.org/10.1186/s12885-024-13350-y

Park HY, Kang D, Shin SH, Choi H, Jang SH, Lee CH, et al. Pulmonary tuberculosis and the incidence of lung cancer among patients with COPD. Ann Am Thorac Soc. 2022; 19(4): 640 8. DOI: https://doi.org/10.1513/annalsats.202010-1240oc

Bhowmik S, Mohanto NC, Sarker D, Sorove AA. Incidence and risk of lung cancer in tuberculosis patients, and vice versa: a literature review of the last decade. Adv Respir Med. 2022; 2022: 1702819. DOI: https://doi.org/10.1155/2022/1702819

Liao KM, Shu CC, Liang FW, Chen YC, Yu CH, Wang JJ, et al. Risk factors for pulmonary tuberculosis in patients with lung cancer: A retrospective cohort study. J Cancer. 2023; 14(4): 657–64. DOI: https://doi.org/10.7150/jca.81616 .

Cioti C, Tica I, Gherase-Cristian MC, Fricatel G, Arghir OC. Tuberculosis preceding lung cancer: A contemporary observational study. Cancers (Basel). 2026; 18(7): 1097. DOI: https://doi.org/10.3390/cancers18071097

Zhou W, Lu H, Lin J, Zhu J, Liang J, Xie Y, et al. Coexisting lung cancer and pulmonary tuberculosis: A comprehensive review from incidence to management. Cancer Rep (Hoboken). 2025; 8(5): e70213. DOI: https://doi.org/10.1002/cnr2.70213

Cheng MP, Abou Chakra CN, Yansouni CP, et al. Risk of active tuberculosis in patients with cancer: systematic review and meta analysis. Clin Infect Dis. 2017; 64(5): 635 44. DOI: https://doi.org/10.1093/cid/ciw838

Fatima G, Ahmed Z, Akhtar A, Rehman ST, Ali S, Anan M. Pulmonary tuberculosis masquerading as a mass cancer lesion: case report and literature review. Clin Case Rep. 2024; 12(7): e9155. DOI: https://doi.org/10.1002/ccr3.9155

Afandi H, Yasin M, Afandi Z, Muhammad M, Tareen S, Jan F. Frequency of bronchiectasis in tuberculosis patients: Study from a tertiary care hospital. Pak J Chest Med. 2024; 30(3): 150–4. Available from: https://www.pjcm.net/index.php/pjcm/article/view/934

Rana F, Rana H, Gill J, Saeed K. Epidemiology of lung cancer in Pakistani patients: Our experience at Shaukat Khanum Memorial Cancer Hospital and Research Centre. Ann King Edward Med Univ. 2020; 4(2): 47-49. DOI: https://doi.org/10.21649/akemu.v4i2.3826

Gupta D, Agrawal A, Marwaha RK. Lung carcinoma and pulmonary tuberculosis coexistence: diagnostic challenges. Lung India. 2015; 32(3): 238 244. DOI: https://doi.org/10.4103/0970-2113.156221

Fang C, He X, Tang F, Wang Z, Pan C, Zhang Q, et al. Where lung cancer and tuberculosis intersect: recent advances. Front Immunol. 2025; 16: 1561719. DOI: https://doi.org/10.3389/fimmu.2025.1561719

Luczynski P, Poulin P, Romanowski K, Johnston JC. Tuberculosis and risk of cancer: A systematic review and meta-analysis. PLoS One. 2022; 17(12): e0278661. DOI: https://doi.org/10.1371/journal.pone.0278661

Cotea AA, Constantin AA, Mihaltan FD. Tuberculosis and lung cancer: Insights from a narrative review. Cancers (Basel). 2025; 18(1): 83. DOI: https://doi.org/10.3390/cancers18010083 .

Nakano-Narusawa Y, Yokohira M, Yamakawa K, Ye J, Tanimoto M, Wu L, et al. Relationship between lung carcinogenesis and chronic inflammation in rodents. Cancers (Basel). 2021; 13(12): 2910. DOI: https://doi.org/10.3390/cancers13122910

Hwang SY, Kim JY, Lee HS, Lee S, Kim D, Kim S, Hyun JH, Shin JI, Lee KH, Han SH, Song YG. Pulmonary tuberculosis and risk of lung cancer: a systematic review and meta-analysis. J Clin Med. 2022;11(3):765. DOI: https://doi.org/10.3390/jcm11030765

Appati W, Amenuke DAY, Appati A, Twumasi QO. Pulmonary tuberculosis presenting as bronchogenic carcinoma in a young Ghanaian adult: A case report and review of the literature. Clin Case Rep. 2025; 13(8): e70710. DOI: https://doi.org/10.1002/ccr3.70710

Downloads

Published

30-06-2026

How to Cite

Sikander, K., Asad, F., Ahmed, M., Kumari, P., Ahmed, A., & Channar, A. S. (2026). Determining the frequency of pulmonary tuberculosis in patients presenting with bronchogenic carcinoma at tertiary care hospital, Karachi. Infectious Diseases Journal of Pakistan, 35(2), 168–174. https://doi.org/10.61529/idjp.v35i2.529